Aphanizomenon flos-aquae (AFA) is a Gram-negative nitrogen-fixing freshwater filamentous
cyanobacterium with a rich nutritional profile that is approved for human consumption by …

Intraocular pressure (IOP) reduction is currently the only evidence‐based treatment strategy
for glaucoma. However, IOP control in some individuals is challenging. Despite optimal …

Background and Objective Erythropoietin (EPO) is a candidate neuroprotective drug. We
assessed its long-term safety and efficacy as an adjunct to methylprednisolone in patients …

Erythropoietin (EPO) is a glycoprotein hormone that regulates hematopoiesis in the human
body. The presence of EPO and its receptors in different tissues indicates that this hormone …

Erythropoietin (EPO) is a glycoprotein hormone conventionally thought to be responsible
only in producing red blood cells in our body. However, with the discovery of the presence of …

IL-17–producing CD4+ (Th17) cells are pathogenically linked to autoimmunity and,
specifically, to autoimmune kidney disease. The newly recognized immunoregulatory …

Background The human cytokine erythropoietin conveys neuroprotection in animal models
but has shown ambiguous results in phase 2 clinical trials in patients with optic neuritis. We …

BACKGROUND Methanol is a highly toxic, non-potable alcohol. Outbreaks of methanol
toxicity occur due to its fraudulent addition to alcoholic beverages as a cheaper substitute for …

Optic neuritis can be defined as typical (associated with multiple sclerosis, improving
independent of steroid treatment), or atypical (not associated with multiple sclerosis, steroid …

Purpose To compare the effect of adding recombinant human erythropoietin (rhEPO) to
intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of …